Bausch Health Companies Inc., commonly referred to as Bausch Health, is a prominent global healthcare company headquartered in Canada. Founded in 2013, the company has rapidly established itself in the pharmaceutical and medical device industries, focusing on eye health, gastrointestinal health, and dermatology. With a diverse portfolio of innovative products, Bausch Health is renowned for its commitment to improving patient outcomes through advanced therapies and technologies. Key offerings include prescription medications, over-the-counter products, and surgical devices, all designed to address critical health needs. Bausch Health has achieved significant milestones, including strategic acquisitions that have bolstered its market position. The company continues to be a leader in the healthcare sector, dedicated to enhancing the quality of life for patients worldwide.
How does Bausch Health Cos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bausch Health Cos's score of 43 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Bausch Health Companies Inc., headquartered in Canada, reported total greenhouse gas emissions of approximately 49,906,000 kg CO2e for Scope 1 and about 51,990,000 kg CO2e for Scope 2 (market-based). Additionally, their Scope 3 emissions from waste generated in operations amounted to around 27,107,000 kg CO2e. Bausch Health has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 emissions by 42% by 2030, using a 2020 baseline. This target has been approved by the Science Based Targets initiative (SBTi) and reflects the company's commitment to align with the 1.5°C climate goal. The company also plans to measure and reduce its Scope 3 emissions, demonstrating a comprehensive approach to tackling its carbon footprint. In comparison, in 2022, Bausch Health's Scope 1 emissions were about 46,686,000 kg CO2e, and Scope 2 emissions (market-based) were approximately 50,513,000 kg CO2e, indicating a slight increase in emissions in 2023. The company is actively working towards its reduction targets, which are crucial for mitigating climate change impacts and enhancing sustainability within the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 46,686,000 | 00,000,000 |
| Scope 2 | 50,513,000 | 00,000,000 |
| Scope 3 | 19,260,000 | 00,000,000 |
Bausch Health Cos's Scope 3 emissions, which increased by 41% last year and increased by approximately 41% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 21% of total emissions under the GHG Protocol, with "Waste Generated in Operations" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bausch Health Cos has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Bausch Health Cos's sustainability data and climate commitments